Chronic insomnia
Conditions
Interventions
Cheek needle group:The cheek needle and tricuspid needle technique is performed twice a week for a total of 4 weeks.
The Western medicine group:Estazolam is taken orally, one tablet per night, for a total of 4 weeks.
Sponsors
Changzhou Third People's Hospital
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Age range: 20 - 60 years old, gender not restricted; 2. Meets the diagnostic criteria for chronic insomnia as defined in the 3rd edition of the International Classification of Sleep Disorders (ICSD-3) (duration >= 3 months, with at least 3 nights per week experiencing difficulty falling asleep / maintaining sleep / early awakening, accompanied by daytime functional impairment); 3. Signed the informed consent form, voluntarily participated in this study, and was able to cooperate with the treatment and all evaluations.
Exclusion criteria
Exclusion criteria: 1. Those with severe mental disorders (such as schizophrenia, severe depression/anxiety disorders, etc.), and severe chronic physical diseases of the heart, liver, kidneys, etc.; 2. Those allergic to cheek acupuncture needles or estazolam drugs; 3. Those who have used other sedative-hypnotic drugs within the last 1 month or participated in other clinical studies; 4. Pregnant or lactating women; 5. Those with cognitive dysfunction and unable to cooperate in completing the scale assessment and the research process.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index Score;Insomnia Severity Index Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Neuropeptide Y;P substance;5-hydroxytryptamine 1A receptor;5-hydroxytryptamine 2A receptor; | — |
Countries
China
Contacts
Public ContactHan Hongyue
Changzhou Third People's Hospital
Outcome results
None listed